AGM
IDYA icon

Alpine Global Management’s IDEAYA Biosciences IDYA Stock Holding History

Alpine Global Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,915
Closed -$234K – 575
2021
Q4 		$234K Buy
+9,915
New +$230K 0.03% 457

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Alpine Global Management's IDYA Position: Q1 2022 in Review

Alpine Global Management sold out of IDEAYA Biosciences (IDYA) in Q1 2022, closing a stake of 9,915 shares — an estimated $234K sold.

Alpine Global Management first reported a position in IDYA in Q4 2021 and held it in 1 quarter. The position peaked at $234K in Q4 2021. 103 funds tracked by Wall St. Rank hold IDYA as of Q1 2022.

  • Alpine Global Management reported no remaining IDEAYA Biosciences position as of Q1 2022 after selling out during the quarter.
  • Alpine Global Management sold 9,915 IDEAYA Biosciences shares in Q1 2022, an estimated $234K.
  • Alpine Global Management first reported a position in IDEAYA Biosciences in Q4 2021 and held it in 1 quarter.
  • Alpine Global Management's IDEAYA Biosciences position peaked at $234K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2022.

Based on Alpine Global Management's 13F filing for Q1 2022, filed 13 May 2022.